Cme Group Inc. · NASDAQ:CME
Cme — Q4 2024 Earnings Presentation
8 slides from Cme's earnings presentation, Feb 12, 2025
Slide 1: 4Q 2024 Earnings Commentary
4Q 2024 Earnings Commentary Revenue (millions) Adjusted 4Q and Full-Year 2024 Summary Adjusted Operating Diluted EPS Expense (millions) CME Group’s solid performance in 4Q24 topped off the best year in the company’s history ● Record annual revenue up 10% to $6.1 billion ● Record adjusted operating i
Slide 2: 4Q and Full-Year 2024 Highlights & Commentary
4Q 2024 Earnings Commentary - Unaudited 4Q and Full-Year 2024 Highlights & Commentary (ADV,OI stated in contracts) Solid financial results in 4Q helped to deliver the 3rd consecutive year of record annual revenue and adjusted earnings in 2024 Full-Year Clearing & Transaction Fee Adjusted Financials
Slide 3: Strong new client acquisition across retail and institutional segments
4Q 2024 Earnings Commentary - Unaudited Strong new client acquisition (NCA) across both retail and institutional segments underscores the success of our strategic initiatives and the attractiveness of our diverse product offerings ● Continue to invest in client-centric approach which lays a strong f
Slide 4: Strong Quarter and Record 2024 for Financials
4Q 2024 Earnings Commentary - Unaudited Strong Quarter and Record 2024 for Financials - 4Q24 ADV of 20.6M, down slightly from a strong 4Q23 Annual Interest Rates ADV 13.7 4Q Interest Rates ADV of 13.2M ● Record 4Q Treasury ADV up 2% to 7.9M ○ Record 2-Yr Treasury Note futures ADV up 8% to 1 million
Slide 5: Product Sets
4Q 2024 Earnings Commentary - Unaudited CME Group continues to innovate and leverage the powerful characteristics of our business model to create new liquid markets for our clients ● Launched several new product offerings in 4Q ○ CBL Australian Carbon Credit Unit (ACCU) ○ Yen- and U.S. Dollar-denomi
Slide 6: Financial Results Notes & Guidance
4Q 2024 Earnings Commentary - Unaudited Financial Results ● 4Q24 revenue was $1.5 billion, up 6% versus ● On December 5, 2024, we announced our 4Q23. 4Q24 clearing and transaction fee Board of Directors had authorized a share revenue totaled $1.2 billion, up 4%, including repurchase program of up to
Slide 7: Appendix - Micro Product Quarterly Details
4Q 2024 Earnings Commentary - Unaudited Financial Results Appendix - Micro Product Quarterly Details ADV in thousands / RPC in cents Micro Equity Index Products 4Q22 1Q23 2Q23 3Q23 4Q23 1Q24 2Q24 3Q24 4Q24 (including Micro Crypto) ADV 2,963 2,725 2,099 2,169 2,250 2,336 2,487 2,945 2,486 RPC 22.2 27
Slide 8: Use of Non-GAAP Measures; Forward-Looking Statements
4Q 2024 Earnings Commentary - Unaudited Use of Non-GAAP Measures A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of GAAP to non-GAAP Measures chart at the end of the financial statements posted on the Investor Relatio